Inderpal Singh

Inderpal Singh

Company: Spark Therapeutics

Job title: Immunogenicity Prediction Lead

Seminars:

Employing AAV immunogenicity predictive models for risk assessment of gene therapy products 9:30 am

Learn about the use of novel assays and platforms that can be implemented during the developability of gene therapy products Develop and implement novel predictive immune assays for product characterization and risk assessment of critical quality attributes (CQA) testing Understand the mechanism related to AAV-mediated immune responses which can provide potential solutions to modulate vector…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.